View Older Stories View More Recent Stories

Dec 10, 2019 08:04AM Lineage Cell Therapeutics (LCTX), AgeX Therapeutics (AGE) Announce Issuance of U.S. Patent for Method of Generating Induced Pluripotent Stem Cells
Dec 10, 2019 08:00AM Lineage Cell Therapeutics and AgeX Therapeutics Announce Issuance of U.S. Patent for Method of Generating Induced Pluripotent Stem Cells
Dec 10, 2019 08:00AM AgeX Therapeutics and Lineage Cell Therapeutics Announce Issuance of U.S. Patent for Method of Generating Induced Pluripotent Stem Cells
Nov 15, 2019 08:07AM Lineage Cell Therapeutics (LCTX) Provides Update on SCiStar Clinical Study and OPC1 Spinal Cord Injury Program
Nov 15, 2019 08:00AM Lineage Cell Therapeutics Provides Update on SCiStar Clinical Study and OPC1 Spinal Cord Injury Program
Nov 12, 2019 04:05PM Lineage Cell Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Update
Nov 5, 2019 08:00AM Lineage Cell Therapeutics to Report Third Quarter 2019 Financial Results and Provide Business Update on November 12, 2019
Oct 28, 2019 08:00AM Lineage Cell Therapeutics to Host Therapeutic Area Experts at Solebury Trout Investor Event on November 15, 2019
Oct 23, 2019 08:00AM Lineage Cell Therapeutics Presents Encouraging Data on Vision Restoration Program at Society for Neuroscience’s 49th Annual Scientific Meeting
Oct 22, 2019 08:00AM Lineage Cell Therapeutics to Present at Dawson James Securities 5th Annual Small Cap Growth Conference on October 29, 2019
Oct 14, 2019 01:45PM Lineage Cell Therapeutics Presents New OpRegen® Data at American Academy of Ophthalmology Annual Meeting
Oct 7, 2019 08:00AM Lineage Cell Therapeutics to Chair Session and Present Data on Vision Restoration Program at Society for Neuroscience’s 49th Annual Scientific Meeting on October 23, 2019
Sep 30, 2019 08:00AM Lineage Cell Therapeutics to Present New OpRegen® Data at American Academy of Ophthalmology Annual Meeting on October 14, 2019
Sep 26, 2019 08:00AM Lineage Cell Therapeutics to Present at 2019 Cantor Global Healthcare Conference on October 4, 2019
Sep 25, 2019 08:06AM Lineage Cell Therapeutics (LCTX) Provides Update on Renevia Commercialization Plans
Sep 25, 2019 08:00AM Lineage Cell Therapeutics Provides Update on Renevia® Commercialization Plans
Sep 23, 2019 08:00AM Lineage Cell Therapeutics to Present at 2019 Cell & Gene Meeting on the Mesa on October 3, 2019
Sep 19, 2019 07:05AM Lineage Cell Therapeutics (LCTX) Receives CE Mark Approval for Renevia
Sep 19, 2019 07:00AM Lineage Cell Therapeutics Receives CE Mark Approval for Renevia®
Sep 11, 2019 09:15AM Lineage Cell Therapeutics Conducts Sale of Shares in OncoCyte Corporation
Sep 5, 2019 08:00AM Lineage Cell Therapeutics to Present at H.C. Wainwright 21st Annual Global Investment Conference on September 9, 2019
Sep 4, 2019 08:06AM Lineage Cell Therapeutics (LCTX) Announces Issuance of U.S. Patent for Method of Treating Spinal Cord Injury With Stem Cell-Derived Oligodendrocyte Progenitor Cells
Sep 4, 2019 08:00AM Lineage Cell Therapeutics Announces Issuance of U.S. Patent for Method of Treating Spinal Cord Injury With Stem Cell-Derived Oligodendrocyte Progenitor Cells
Sep 3, 2019 08:00AM Lineage Cell Therapeutics Announces Data From Vision Restoration Program Published in Stem Cells and Development Journal
Aug 26, 2019 08:00AM Lineage Cell Therapeutics Announces Issuance of U.S. Patent for System for Generating Immunogenic Dendritic Cells
Aug 20, 2019 08:00AM Lineage Cell Therapeutics to Ring Opening Bell at the New York Stock Exchange on August 21, 2019
Aug 13, 2019 08:00AM Lineage Cell Therapeutics Awarded NIH Grant for Innovative Vision Restoration Program
Aug 12, 2019 08:00AM Lineage Cell Therapeutics Launches New Corporate Brand
View More Recent Stories View Older Stories